Skip to main content
EN
CH
Hit enter to search or ESC to close
Close Search
search
Menu
Juvelook & Lenisna
What is PDLLA
Benefits
Juvelook
Lenisna
Before & After
Juvelook
Lenisna
Media
JULIA
Newsletter
Conference
Clinical study
News
FAQ
Contact us
search
News
News
Total 31
Newest
Best
Viewed
Updated
Number
Thumbnail
Title
Date
Notice
[Announcement] Official Letter Confirming VAIM’s Patent Ownership and Technological Independence
|
2025.07.04
2025.07.04
10
JUVELOOK Celebrates One Million Vial Milestone
|
2025.01.23
2025.01.23
9
VAIM Global Participates in AMWC ASIA...Expanding Its Footprint in Asia
|
2024.06.10
2024.06.10
8
VAIM GLOBAL held 'JUVELOOK' Master Class for Local Medical Professionals in Singapore
|
2024.06.07
2024.06.07
7
"Medical Aesthetic" VAIM, Selected as Outstanding Bio Company for 3 Consecutive Years
|
2024.05.16
2024.05.16
6
VAIM Commences Operations of New Factory in Daejeon... JVUELOOK Production Capacity Triples
|
2024.05.13
2024.05.13
5
VAIM GLOBAL Introduces QR Authentication Service for 'JUVELOOK·LENISNA'
|
2024.04.26
2024.04.26
4
Jong Wang Kim, CEO of VAIM GLOBAL, "We will lead the global medical device market with JUVELOOK" [Interview]
|
2024.04.24
2024.04.24
3
'JUVELOOK' Launch Symposium in Thailand
|
2024.04.12
2024.04.12
2
VAIM GLOBAL Participates in "IMCAS 2024" for the Third Consecutive Year
|
2024.04.09
2024.04.09
1
‘Ready Dermatology’ exceeds 5,000 vials of JUVELOOK and LENISNA
|
2024.02.28
2024.02.28
First
«
1
2
3
All
Title
Content
Author
Search
Powered by KBoard
Contact Us
+82-2-6214-0857
official@vaim.co.kr
Connect
Close Menu
Juvelook & Lenisna
What is PDLLA
Benefits
Juvelook
Lenisna
Before & After
Juvelook
Lenisna
Media
JULIA
Newsletter
Conference
Clinical study
News
FAQ
Contact us
EN
CH